1065343 Stock Overview
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 4/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Edwards Lifesciences Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$83.18 |
| 52 Week High | US$68.77 |
| 52 Week Low | US$68.77 |
| Beta | 1.07 |
| 1 Month Change | 1.86% |
| 3 Month Change | n/a |
| 1 Year Change | 8.37% |
| 3 Year Change | -43.13% |
| 5 Year Change | 37.01% |
| Change since IPO | 219.93% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1065343 | CH Medical Equipment | CH Market | |
|---|---|---|---|
| 7D | 0% | -1.0% | 0.03% |
| 1Y | 8.4% | 4.7% | -3.3% |
Return vs Industry: 001065343 exceeded the Swiss Medical Equipment industry which returned 4.7% over the past year.
Return vs Market: 001065343 exceeded the Swiss Market which returned -3.3% over the past year.
Price Volatility
| 1065343 volatility | |
|---|---|
| 1065343 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 3.7% |
| Market Average Movement | 3.5% |
| 10% most volatile stocks in CH Market | 7.5% |
| 10% least volatile stocks in CH Market | 2.0% |
Stable Share Price: 001065343 has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine 001065343's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1958 | 19,800 | Bernard Zovighian | www.edwards.com |
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve.
Edwards Lifesciences Corporation Fundamentals Summary
| 1065343 fundamental statistics | |
|---|---|
| Market cap | CHF48.38b |
| Earnings (TTM) | CHF1.29b |
| Revenue (TTM) | CHF5.61b |
37.5x
P/E Ratio8.6x
P/S RatioIs 1065343 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1065343 income statement (TTM) | |
|---|---|
| Revenue | US$6.14b |
| Cost of Revenue | US$1.44b |
| Gross Profit | US$4.71b |
| Other Expenses | US$3.29b |
| Earnings | US$1.41b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 2.35 |
| Gross Margin | 76.63% |
| Net Profit Margin | 23.01% |
| Debt/Equity Ratio | 8.3% |
How did 1065343 perform over the long term?
See historical performance and comparison